Who owns ACURX PHARMACEUTICALS INC COM NEW?
- Ticker: ACXP
- CUSIP Number: 00510m203
Tip: Access positions for across all investors
Analyze quarterly positions in Acurx Pharmaceuticals with up to 7 years of data, all consolidated into one spreadsheet
Download as csv
Download as Excel
Top investors of Acurx Pharmaceuticals stock
Who bought or sold ACURX PHARMACEUTICALS INC COM NEW this quarter?
| Fund or Company Name | Shares Held | Valued At | Change in Shares | As Of | Actions |
|---|---|---|---|---|---|
| Vanguard Capital Management | 31k | $48k | 0% | Jun 2026 |
|
| Geode Capital Management | 26k | $41k | 6% | Jun 2026 |
|
| Vanguard Fiduciary Trust | 16k | $25k | 0% | Jun 2026 |
|
| Jane Street | 16k | $24k | -71% | Jun 2026 |
|
| Prospect Financial Services | 14k | $21k | 0% | Jun 2026 |
|
| Morgan Stanley | 6.5k | $24k | 0% | Mar 2026 |
|
| Tower Research Capital | 2.7k | $4.3k | 166% | Jun 2026 |
|
| Wells Fargo & Company | 2.3k | $3.6k | 0% | Jun 2026 |
|
| Westside Investment Management | 1.7k | $2.6k | 0% | Jun 2026 |
|
| Nbc Securities | 1.5k | $2.3k | 0% | Jun 2026 |
|
| Barclays | 281.00 | $435.999600 | -26% | Jun 2026 |
|
| Cornerstone Planning Group | 167.00 | $245.005700 | 0% | Jun 2026 |
|
| Advisor Group Holdings | 100.00 | $155.000000 | 0% | Jun 2026 |
|
| Group One Trading | 95.00 | $147.003000 | -61% | Jun 2026 |
|
| BlackRock | 60.00 | $93.000000 | 0% | Jun 2026 |
|
| Caitong International Asset Management | 23.00 | $35.999600 | 100% | Jun 2026 |
|
| SBI Securities | 6.00 | $9.000000 | 0% | Jun 2026 |
|
| UBS Group | 3.00 | $5.000100 | -100% | Jun 2026 |
|
| Citigroup | 1.00 | $4.000000 | 100% | Mar 2026 |
|
Who sold out of Acurx Pharmaceuticals?
| Fund or Company Name | Date Sold | Shares Held | Valued At |
|---|---|---|---|
| Cambridge Investment Research Advisors | Mar 2026 | 20k | $74k |
| Mcguire Capital Advisors | Mar 2026 | 1.0k | $3.7k |
| Advisory Services Network | Mar 2026 | 59.00 | $219.002100 |